IP Verse

Small Scale Cultivation Method For Suspension Cells - EP3303557

The patent EP3303557 was granted to Glycotope on May 5, 2021. The application was originally filed on May 25, 2016 under application number EP16727348A. The patent is currently recorded with a legal status of "Revoked".

EP3303557

GLYCOTOPE
Application Number
EP16727348A
Filing Date
May 25, 2016
Status
Revoked
Jan 12, 2024
Publication Date
May 5, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SARTORIUS STEDIM BIOTECHFeb 4, 2022MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBADMISSIBLE
STRAWMANFeb 3, 2022VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP0599651
INTERNATIONAL-SEARCH-REPORTUS2004185534
INTERNATIONAL-SEARCH-REPORTWO2012085162
OPPOSITIONCN104195187
OPPOSITIONEP0599651
OPPOSITIONEP2599651
OPPOSITIONUS2004185534
OPPOSITIONUS2004185535
OPPOSITIONWO2007071072
OPPOSITIONWO2008152075
OPPOSITIONWO2012085162
OPPOSITIONWO2016193083

Non-Patent Literature (NPL) Citations (30) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- HSU ET AL., CYTOTECHNOLOGY, (2012), vol. 64, pages 667 - 678
DESCRIPTION- SHIMONI ET AL., BIOPROCESS INT, (2014), vol. 12, pages 54 - 61
DESCRIPTION- VOISARD ET AL., BIOTECHOL BIOENG, (2003), vol. 82, pages 751 - 765
INTERNATIONAL-SEARCH-REPORT- Nicole A. Bleckwenn ET AL, "Large-Scale Cell Culture", Current Protocols in Immunology, Hoboken, NJ, USA, John Wiley & Sons, Inc., (20040101), doi:10.1002/0471142735.ima01us59, ISBN 978-0-47-114273-7, XP055041131 [Y] 1-15 * page 10 *
INTERNATIONAL-SEARCH-REPORT- MORAN E B ET AL, "A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, (20000805), vol. 69, no. 3, doi:10.1002/1097-0290(20000805)69:3<242::AID-BIT2>3.0.CO;2-I, ISSN 0006-3592, pages 242 - 255, XP002409406 [A] 1-15 * the whole document *
INTERNATIONAL-SEARCH-REPORT- CHU L ET AL, "Industrial choices for protein production by large-scale cell culture", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, (20010101), vol. 12, doi:10.1016/S0958-1669(00)00197-X, ISSN 0958-1669, pages 180 - 187, XP003014088 [A] 1-15 * the whole document *
INTERNATIONAL-SEARCH-REPORT- STEVEN M WOODSIDE ET AL, "Mammalian cell retention devices for stirred perfusion bioreactors", CYTOTECHNOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, (19980901), vol. 28, no. 1-3, doi:10.1023/A:1008050202561, ISSN 1573-0778, pages 163 - 175, XP019236582 [Y] 1-15 * page 169 - page 171; figure 3 *
INTERNATIONAL-SEARCH-REPORT- FENG LI ET AL, "Cell culture processes for monoclonal antibody production", MABS, (20100901), vol. 2, no. 5, doi:10.4161/mabs.2.5.12720, ISSN 1942-0862, pages 466 - 479, XP055166177 [A] 1-15 * the whole document *
OPPOSITION- Anonymous, "TAP Biosystems, New Application Of TAP's ambr Microscale Bioreactor As Perfusion Mimic", Bioprocess Online, (20131015), pages 1 - 1, Bioprocess Online, URL: https://www.bioprocessonline.com/doc/tap-s-ambr-microscale-bioreactor-as-perfusion-mimic-0001, (20220216), XP055892369
OPPOSITION- Finesse launches next generation SmartGlass 3L bioreactor for cell culture and fermentation, (20130619), URL: https://www.biospace.com/article/releases/finesse-solutions-launches-next- generation-smartglass-31-bioreactors-for- cell -culture-and-fermentation
OPPOSITION- Hsu Wei-Ting, Et Al, "Advanced microscale bioreactor system: a representative scale-down model for bench-top bioreactors", Cytotechnology, (20120101), vol. 64, pages 667 - 678, XP055892364
OPPOSITION- JULIEN AND WHITFORD, "Bioreactor monitoring, modeling and simulation.", Bioprocess International, (20070100), pages 10 - 17, XP055895098
OPPOSITION- Kaiser Stephan C, "Novel CHO Suspension Cell Cultivation", (20130801), pages 1 - 6, URL: https://www.genengnews.com/magazine/20 7/novel-cho-suspension- cell-cultivation, (20220216), XP055892389
OPPOSITION- "New application of TAP's ambr microscale bioreactor as perfusion mimic", Bioprocess Online News, (20131015), URL: https://www.bioprocessonline.com/doc/tap-s-ambr-microscale-bioreactor-as-perfusion-mimic-0001, XP055892369
OPPOSITION- Sargent Brandy, "Perfusion Bioreactors - With so much to offer they deserve a closer look", (20130612), pages 1 - 6, URL: https://cellculturedish.com/perfusion-bioreactors-with-so- much-to-offer-they-deserve-a-closer-look, (20220216), XP055892373
OPPOSITION- SmartGlass Bioreactor - Finesse, (20150410), URL: https://biopharma- asia.com/products/smartglass-bioreactor-finesse
OPPOSITION- BLECKWENN et al., Current Protocols in Immunology, (20040000), URL: https://doi.org/10.1002/0471142735.ima01 us59, XP055041131
OPPOSITION- "Large-Scale Cell Culture", Nicole A. Bleckwenn, Joseph Shiloach, Current Protocols in Immunology, (20040101), pages A.1U.1 - A.1U.44, Apendix 1U, Suppl. 59, doi:10.1002/0471142735.ima01us59, XP055041131
OPPOSITION- MORAN et al., "A Systematic Approach to the Validation of Process Control Parameters for Monoclonal Antibody Production in Fed-Batch Culture of a Murine Myeloma", Biotechnol Bioeng, (20000000), vol. 69, doi:10.1002/1097-0290(20000805)69:3<242::AID-BIT2>3.0.CO;2-I, pages 242 - 255, XP002409406
OPPOSITION- VOISARD et al., "Potential of cell retention techniques for large- scale high density perfusion culture of suspended mammalian cells.", Biotechnol Bioeng, (20030000), vol. 82, doi:10.1002/bit.10629, pages 751 - 765, XP002317548
OPPOSITION- HÃœLSCHER et al., "Selective Recycle of Viable Animal Cells by Coupling of Airlift Reactor and Cell Settler", Biotechnology and Bioengineering, (19920000), vol. 39, doi:10.1002/bit.260390410, pages 442 - 446, XP000247082
OPPOSITION- Kim et al., "Mini-scale bioprocessing systems for highly parallel animal cell cultures", Biotechnology Progress, (20120501), vol. 28, no. 3, doi:10.1002/btpr.1554, ISSN 8756-7938, pages 595 - 607, XP055895095
OPPOSITION- BERRIOS et al., "Continuous CHO cell cultures with improved recombinant protein productivity by using mannose as carbon source: Metabolic analysis and scale-up simulation", Chemical Engineering Sciences, (20110316), vol. 66, doi:10.1016/j.ces.2011.03.011, pages 2431 - 2439, XP028188909
OPPOSITION- KEMPF et al., Stem Cell Reports, (20140000), vol. 3, pages 1132 - 1146, XP055452339
OPPOSITION- SANDERSON et al., "Simulation and dynamic optimization of animal cell culture", Cytotechnology, (19970000), vol. 23, pages 13 - 17, XP055895091
OPPOSITION- WOODSIDE et al., Cytotechnology, (19980000), vol. 28, pages 163 - 175, XP019236582
OPPOSITION- WOODSIDE et al., "Mammalian cell retention devices for stirred perfusion bioreactors.", Cytotechnology, (19980000), vol. 28, doi:10.1023/A:1008050202561, pages 163 - 175, XP002301951
OPPOSITION- SIDOLI et al., "Modelling of mammalian cells and cell culture processes", Cytotechnology, (20140000), vol. 44, pages 27 - 46, XP055895092
OPPOSITION- Wurm Florian M, "Production of recombinant protein therapeutics in cultivated mammalian cells", Nature Biotechnology, New York, (20041101), vol. 22, no. 11, doi:10.1038/nbt1026, ISSN 1087-0156, pages 1393 - 1398, XP037152042
OPPOSITION- LI et al., "Cell culture processes for monoclonal antibody production", mAbs, (20100901), vol. 2, no. 5, doi:10.4161/mabs.2.5.12720, pages 466 - 479, XP055166177

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents